Cancer Keys: Jaundice and Pancreatic Cancer

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Potential pitfall:

Jaundice can be a classic symptom of pancreatic cancer; about half of patients have jaundice when they first go to their GP. Yet, pancreatic cancer is difficult to diagnose as symptoms can vary or may be late, vague and non-specific.

Helpful hint:

Symptoms of pancreatic cancer usually develop over a short number of months. The NICE NG12 guideline recommends referring people using a suspected cancer pathway referral, (for an appointment within 2 weeks), for pancreatic cancer if they are aged 40 and over and have jaundice.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

Read the NICE NG12 guidance here

Access GatewayC’s Pancreatic Cancer – Early Diagnosis course here

LinkedIn Twitter | Facebook

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more